Selective estrogen receptor modulators and cardiovascular events.
نویسنده
چکیده
ost of the previous observational studies suggest that estrogen replacement therapy reduces cardiovascular risks,1 but meta-analysis of randomized clinical trials showed increased risk of hormone replacement therapy for cardiovascular events.2 Both hypercoagulability and upregulation of inflammation-sensitive proteins could underline the increased risk of estrogen treatment in coronary artery disease (CAD) and ischemic stroke. Article p 135
منابع مشابه
Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease.
The cloning of estrogen receptors (ERs) and generation of ER-deficient mice have increased our understanding of the molecular mechanisms underlying the cardiovascular effects of estrogen. It is conceivable that clinical trials of estrogens so far failed to improve cardiovascular health because of the poor ER isoform selectivity and tissue specificity of endogenous hormones as well as incorrect ...
متن کاملSelective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
The ideal selective estrogen receptor modulator will protect against fractures, prevent estrogen receptor-positive breast cancer, suppress vasomotor symptoms, offer cardiovascular protection, maintain vaginal and bladder health and prevent endometrial stimulation, with an acceptable safety and tolerability profile. Raloxifene is available in most countries and has been approved for the preventi...
متن کاملAlternatives to the use of estrogen in postmenopausal women.
A. Estrogens and primary prevention of cardiovas-cular disease B. Comparison of statins with estrogens for primary prevention of cardiovascular disease C. Effects of statins on new coronary events and survival D. Other agents with potential for prevention of car-diovascular disease E. Secondary prevention of cardiovascular disease III. Prevention and Treatment of Osteoporosis A. Estrogen therap...
متن کاملNew Selective Estrogen Receptor Modulators (SERMs) in Development
Selective estrogen receptor modulators (SERMs) or estrogen agonists/antagonists have shown promise in osteoporosis in that they have the potential to reduce the risk of fracture, and also reduce the risk of breast cancer. SERMs maybe classified according to their core structure, which is typically a variation of the 17 beta-estradiol template and subclassified according to the side chain at the...
متن کاملManaging the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolism, and blood clotting. Raloxifene significantly improves serum lipids and serum markers of cardiovascular disease risk, but it has no significant effect on the risk of primary coronary events. A meta-analysis o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation journal : official journal of the Japanese Circulation Society
دوره 78 1 شماره
صفحات -
تاریخ انتشار 2014